Featured Research

from universities, journals, and other organizations

Safer Gene Therapy May Be Possible Using Novel Approach

Date:
March 21, 2008
Source:
Sbarro Health Research Organization
Summary:
A novel strategy for circumventing safety problems that have plagued gene therapy has been offered by a complex multicenter group of researchers. The study reports that adenovirus type 5, a common vector for delivering gene therapy, transfects liver cells by a different mechanism than previously thought. That mechanism offers a new target for modifying the viral vector to make it safe for clinical use.

A novel strategy for circumventing safety problems that have plagued gene therapy has been offered by a complex multicenter group of researchers, including Professor Claudio Napoli, a Full Professor at the II University of Naples and Adjunct Professor at the Sbarro Research Institute for Cancer Research and Molecular Medicine and the Center of Biotechnology at the College of Science and Technology of Temple University.

Related Articles


The study reports that adenovirus type 5, a common vector for delivering gene therapy, transfects liver cells by a different mechanism than previously thought. That mechanism offers a new target for modifying the viral vector to make it safe for clinical use.

A number of studies indicated that it would be possible to use adenovirus as a vector to deliver genes into specific locations, such as a solid tumor. But when it's injected intravenously, the virus accumulates in the liver instead of circulating in the body, raising the risk of toxicity and transfection of other cells.

Basically, adenovirus consists of three major proteins - fiber, penton and hexon. Based on earlier work, most researchers held that the main mechanism of viral transduction was the fiber protein's interaction with a receptor on the target cell. But attempts to mutate the fiber protein did not block the virus's accumulation in the liver in vivo.

Professor Andrew Baker of the University of Glasgow, who led the current research, notes that all of these fiber-modified viruses still ended up transducing the liver. The Cell paper focused instead on the hexon protein. The researchers mutated the protein, disabling its ability to interact with a blood-clotting enzyme, Factor X. Those mutations, and pharmacological blockade of the interaction, did indeed block gene transfer, suggesting that the virus enters liver cells via the interaction of the hexon protein and Factor X.

The researchers noted that fiber-mediated transduction works when the virus is injected in muscle or cell culture, but when injected into the bloodstream, this mechanism takes over.

“Now that we have learned the mechanism that an adenovirus uses we could modify that process by genetically engineering the virus, to improve uptake into several cell types, including stem cells,” says Dr. Napoli.

The study was published online in the journal Cell (Cell 2008 Feb 8;132:397-409).


Story Source:

The above story is based on materials provided by Sbarro Health Research Organization. Note: Materials may be edited for content and length.


Cite This Page:

Sbarro Health Research Organization. "Safer Gene Therapy May Be Possible Using Novel Approach." ScienceDaily. ScienceDaily, 21 March 2008. <www.sciencedaily.com/releases/2008/03/080320192009.htm>.
Sbarro Health Research Organization. (2008, March 21). Safer Gene Therapy May Be Possible Using Novel Approach. ScienceDaily. Retrieved October 25, 2014 from www.sciencedaily.com/releases/2008/03/080320192009.htm
Sbarro Health Research Organization. "Safer Gene Therapy May Be Possible Using Novel Approach." ScienceDaily. www.sciencedaily.com/releases/2008/03/080320192009.htm (accessed October 25, 2014).

Share This



More Health & Medicine News

Saturday, October 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com
Doctor in NYC Quarantined With Ebola

Doctor in NYC Quarantined With Ebola

AP (Oct. 24, 2014) An emergency room doctor who recently returned to the city after treating Ebola patients in West Africa has tested positive for the virus. He's quarantined in a hospital. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins